Gray Nancy Ryan
SEC insider (Form 3/4/5 filer). CIK 0001714949. Director at LIGAND PHARMACEUTICALS INC (LGND). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in JUPITER, FL.
Companies Gray Nancy Ryan has filed insider reports for
- LIGAND PHARMACEUTICALS INC (LGND): Director
Gray Nancy Ryan
CIK: 0001714949
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)2 (33.3%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LGND
LIGAND PHARMACEUTICALS INC
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 5, 2026LGND
LIGAND PHARMACEUTICALS INC
AwardDirect836 shares- - Nov 7, 2025LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect3.6K shares at avg. $66.19$235K - Nov 7, 2025LGND
LIGAND PHARMACEUTICALS INC
SaleDirect3.6K shares at avg. $205.45$731K - Nov 7, 2025LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect3K shares at avg. $73.57$222K - Nov 7, 2025LGND
LIGAND PHARMACEUTICALS INC
SaleDirect3K shares at avg. $205.45$619K - Jun 6, 2025LGND
LIGAND PHARMACEUTICALS INC
AwardDirect1.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | LGND LIGAND PHARMACEUTICALS INC | Award | 836 | - | $0 | Direct |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 3,556 | $66.19 | $235,372 | Direct |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | Sale | 3,556 | $205.45 | $730,580 | Direct |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 3,015 | $73.57 | $221,814 | Direct |
| Nov 7, 2025 | LGND LIGAND PHARMACEUTICALS INC | Sale | 3,015 | $205.45 | $619,432 | Direct |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | Award | 1,209 | - | - | Direct |
1-6 of 6 transactions